Subscribe to RSS
DOI: 10.5999/aps.2015.42.3.321
Daily Serum Collection after Acellular Dermal Matrix-Assisted Breast Reconstruction
Background The acellular dermal matrix (ADM)-assisted breast reconstruction technique is widely known, but discouraging results due to early postoperative complications have been reported. As the literature identifies seroma as the most common issue after breast surgery without identifying its pathogenesis, we aimed to report the trend of postoperative daily serum collection after ADM-assisted breast reconstruction and compare it with data in the literature in order to discover more about this little-known topic.
Methods A retrospective study on 28 consecutive patients who received ADM-assisted breast reconstruction between February 2013 and February 2014 was performed. In order to reduce the number of variables that could affect serum production, only one brand of ADM was used and all tissues were handled gently and precisely. The daily drainage volume was recorded per patient during the first four days of hospitalization. Likewise, postoperative complications were noted during routine follow-up.
Results In total, five (17.9%) bilateral and 23 (82.1%) unilateral ADM-assisted breast reconstructions (33 implants) were performed. The mean age, body mass index, and length of hospital stay were 53.6 years, 21.3 kg/m2, and 4.5 days, respectively. One major complication led to implant loss (3.0%), and nine minor complications were successfully treated with ambulatory surgery (27.3%). Serum collection linearly decreased after 24 hours postoperatively.
Conclusions Daily drainage decreased following the theoretical decline of acute inflammation. In concordance with the literature, daily serum production may not be related to the use of ADM.
The authors thank the Department of Anatomical Pathology at the University Hospital of Verona and Dr. Marina Zannoni for providing the specimen histological analysis.
Publication History
Received: 05 September 2014
Accepted: 05 November 2014
Article published online:
05 May 2022
© 2015. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 1 Salzberg CA, Ashikari AY, Koch RM. et al. An 8-year experience of direct-to-implant immediate breast reconstruction using human acellular dermal matrix (AlloDerm). Plast Reconstr Surg 2011; 127: 514-524
- 2 Johnson RK, Wright CK, Gandhi A. et al. Cost minimisation analysis of using acellular dermal matrix (Strattice) for breast reconstruction compared with standard techniques. Eur J Surg Oncol 2013; 39: 242-247
- 3 Zienowicz RJ, Karacaoglu E. Implant-based breast reconstruction with allograft. Plast Reconstr Surg 2007; 120: 373-381
- 4 Hoppe IC, Yueh JH, Wei CH. et al. Complications following expander/implant breast reconstruction utilizing acellular dermal matrix: a systematic review and meta-analysis. Eplasty 2011; 11: e40
- 5 Sbitany H, Serletti JM. Acellular dermis-assisted prosthetic breast reconstruction: a systematic and critical review of efficacy and associated morbidity. Plast Reconstr Surg 2011; 128: 1162-1169
- 6 Chun YS, Verma K, Rosen H. et al. Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications. Plast Reconstr Surg 2010; 125: 429-436
- 7 Kuroi K, Shimozuma K, Taguchi T. et al. Evidence-based risk factors for seroma formation in breast surgery. Jpn J Clin Oncol 2006; 36: 197-206
- 8 Srivastava V, Basu S, Shukla VK. Seroma formation after breast cancer surgery: what we have learned in the last two decades. J Breast Cancer 2012; 15: 373-380
- 9 Zielinski J, Jaworski R, Irga N. et al. Analysis of selected factors influencing seroma formation in breast cancer patients undergoing mastectomy. Arch Med Sci 2013; 9: 86-92
- 10 Michelotti BF, Brooke S, Mesa J. et al. Analysis of clinically significant seroma formation in breast reconstruction using acellular dermal grafts. Ann Plast Surg 2013; 71: 274-277
- 11 Brzezienski MA, Jarrell 4th JA, Mooty RC. Classification and management of seromas in immediate breast reconstruction using the tissue expander and acellular dermal matrix technique. Ann Plast Surg 2013; 70: 488-492
- 12 Carlson TL, Lee KW, Pierce LM. Effect of cross-linked and non-cross-linked acellular dermal matrices on the expression of mediators involved in wound healing and matrix remodeling. Plast Reconstr Surg 2013; 131: 697-705
- 13 Mestak O, Spurkova Z, Benkova K. et al. Comparison of cross-linked and non-cross-linked acellular porcine dermal scaffolds for long-term full-thickness hernia repair in a small animal model. Eplasty 2014; 14: e22
- 14 Porter KA, O'Connor S, Rimm E. et al. Electrocautery as a factor in seroma formation following mastectomy. Am J Surg 1998; 176: 8-11
- 15 Ozdogan M, Yilmaz KB, Ozaslan C. et al. Scalpel versus electrocautery dissections: the effect on wound complications and pro-inflammatory cytokine levels in wound fluid. Turk J Med Sci 2008; 38: 111-116
- 16 Van den Broek PJ, Buys LF, Van Furth R. Interaction of povidone-iodine compounds, phagocytic cells, and microorganisms. Antimicrob Agents Chemother 1982; 22: 593-597
- 17 Adams Jr WP, Conner WC, Barton Jr FE. et al. Optimizing breast pocket irrigation: an in vitro study and clinical implications. Plast Reconstr Surg 2000; 105: 334-338
- 18 Salzberg CA. Direct-to-implant breast reconstruction with Acellular Dermal Matrix. In: Spear SL, Robb GL, Hammond DC. et al. Surgery of the breast: principles and art. 3rd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2010: 412-419
- 19 Ganske I, Verma K, Rosen H. et al. Minimizing complications with the use of acellular dermal matrix for immediate implant-based breast reconstruction. Ann Plast Surg 2013; 71: 464-470
- 20 Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002; 2: 787-795
- 21 Szecsi PB, Larsen J, Horby J. et al. Seroma production after breast cancer surgery has a pro-inflammatory component. Open Breast Cancer J 2012; 4: 11-17
- 22 Sampathraju S, Rodrigues G. Seroma formation after mastectomy: pathogenesis and prevention. Indian J Surg Oncol 2010; 1: 328-333
- 23 Badylak SF. Decellularized allogeneic and xenogeneic tissue as a bioscaffold for regenerative medicine: factors that influence the host response. Ann Biomed Eng 2014; 42: 1517-1527
- 24 Lin YP, Yin WJ, Yan TT. et al. Risk factors for postoperative seromas in Chinese breast cancer patients. Chin Med J (Engl) 2011; 124: 1300-1304
- 25 Gonzalez EA, Saltzstein EC, Riedner CS. et al. Seroma formation following breast cancer surgery. Breast J 2003; 9: 385-388